Hemo Organic Limited (BOM:524590)
India · Delayed Price · Currency is INR 19.90
-1.04 (-4.97%)
At close: Aug 17, 2026
Hemo Organic Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 9.27 | 9.29 | 24.14 | 0.22 | 0.05 | 0.07 |
Other Revenue | 0.02 | 0.02 | 0.7 | 0 | - | - |
| 9.29 | 9.31 | 24.84 | 0.23 | 0.05 | 0.07 | |
Revenue Growth | -62.63% | -62.52% | 10892.03% | 370.83% | -29.72% | -15.37% |
Cost of Revenue | 9.28 | 9.29 | 22 | 0.15 | 0.02 | 0.09 |
Gross Profit | 0.01 | 0.02 | 2.85 | 0.07 | 0.03 | -0.02 |
Selling, General & Admin | 0.5 | 0.65 | 0.38 | 0.4 | - | 0.36 |
Other Operating Expenses | 4.08 | 4.34 | 2.22 | 2.04 | 0.58 | 0.24 |
Operating Expenses | 4.59 | 5 | 2.59 | 2.44 | 0.58 | 0.6 |
Operating Income | -4.58 | -4.98 | 0.26 | -2.37 | -0.55 | -0.62 |
Interest Expense | - | - | -0 | -0.2 | - | -0 |
EBT Excluding Unusual Items | -4.58 | -4.98 | 0.26 | -2.57 | -0.55 | -0.62 |
Pretax Income | -4.58 | -4.98 | 0.26 | -2.57 | -0.55 | -0.62 |
Income Tax Expense | 3.09 | 2.8 | -1.38 | 0.07 | - | - |
Net Income | -7.67 | -7.78 | 1.64 | -2.64 | -0.55 | -0.62 |
Net Income to Common | -7.67 | -7.78 | 1.64 | -2.64 | -0.55 | -0.62 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change | -0.55% | 0.22% | - | - | - | - |
EPS (Basic) | -2.19 | -2.24 | 0.47 | -0.76 | -0.16 | -0.18 |
EPS (Diluted) | -2.19 | -2.24 | 0.47 | -0.76 | -0.16 | -0.18 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -14.6 | -3.62 | -11.91 | 1.07 | -0.04 |
Free Cash Flow Per Share | - | -4.20 | -1.04 | -3.44 | 0.31 | -0.01 |
Gross Margin | 0.13% | 0.18% | 11.46% | 32.30% | 66.67% | -36.47% |
Operating Margin | -49.30% | -53.52% | 1.03% | -1047.79% | -1137.50% | -911.63% |
Profit Margin | -82.51% | -83.58% | 6.60% | -1168.58% | -1137.50% | -913.15% |
Free Cash Flow Margin | - | -156.78% | -14.56% | -5267.70% | 2231.25% | -64.85% |
EBITDA | -4.57 | -4.98 | - | - | - | - |
EBITDA Margin | -49.23% | -53.46% | - | - | - | - |
D&A For EBITDA | 0.01 | 0.01 | - | - | - | - |
EBIT | -4.58 | -4.98 | 0.26 | -2.37 | -0.55 | -0.62 |
EBIT Margin | -49.30% | -53.52% | 1.03% | - | - | - |
Revenue as Reported | 9.29 | 9.31 | 24.84 | 0.23 | 0.05 | 0.07 |
Advertising Expenses | - | - | 0.03 | 0 | - | - |